HI
CL icon

Human Investing’s Colgate-Palmolive CL Stock Holding History

Human Investing’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,009
Closed -$312K – 330
2024
Q3 		$312K Sell
3,009
-476
-14% -$48.5K 0.06% 76
2024
Q2 		$338K Sell
3,485
-533
-13% -$49.2K 0.07% 70
2024
Q1 		$362K Sell
4,018
-345
-8% -$29.2K 0.07% 70
2023
Q4 		$348K Sell
4,363
-1,599
-27% -$120K 0.08% 72
2023
Q3 		$424K Sell
5,962
-739
-11% -$55.3K 0.1% 69
2023
Q2 		$516K Sell
6,701
-802
-11% -$62.1K 0.12% 62
2023
Q1 		$564K Sell
7,503
-2,299
-23% -$171K 0.14% 60
2022
Q4 		$772K Sell
9,802
-3,208
-25% -$241K 0.2% 54
2022
Q3 		$914K Buy
13,010
+195
+2% +$15.3K 0.23% 52
2022
Q2 		$1.03M Sell
12,815
-93
-0.7% -$7.27K 0.25% 55
2022
Q1 		$979K Sell
12,908
-981
-7% -$77.7K 0.22% 65
2021
Q4 		$1.19M Sell
13,889
-30
-0.2% -$2.34K 0.28% 53
2021
Q3 		$1.05M Buy
13,919
+1,285
+10% +$102K 0.25% 69
2021
Q2 		$1.03M Sell
12,634
-363
-3% -$29.7K 0.25% 74
2021
Q1 		$1.02M Sell
12,997
-754
-5% -$59.1K 0.26% 76
2020
Q4 		$1.18M Sell
13,751
-545
-4% -$45.1K 0.33% 64
2020
Q3 		$1.1M Sell
14,296
-611
-4% -$46.6K 0.36% 71
2020
Q2 		$1.09M Sell
14,907
-502
-3% -$35.7K 0.39% 62
2020
Q1 		$1.02M Sell
15,409
-2,123
-12% -$150K 0.44% 58
2019
Q4 		$1.21M Buy
17,532
+35
+0.2% +$2.39K 0.39% 74
2019
Q3 		$1.29M Sell
17,497
-1,310
-7% -$95K 0.46% 68
2019
Q2 		$1.35M Sell
18,807
-317
-2% -$22.5K 0.49% 65
2019
Q1 		$1.31M Buy
19,124
+1
+0% +$65 0.49% 65
2018
Q4 		$1.14M Buy
+19,123
New +$1.2M 0.47% 66

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Human Investing's CL Position: Q4 2024 in Review

Human Investing sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 3,009 shares — an estimated $312K sold.

Human Investing first reported a position in CL in Q4 2018 and held it in 24 quarters. The position peaked at $1.35M in Q2 2019. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Human Investing reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • Human Investing sold 3,009 Colgate-Palmolive shares in Q4 2024, an estimated $312K.
  • Human Investing first reported a position in Colgate-Palmolive in Q4 2018 and held it in 24 quarters.
  • Human Investing's Colgate-Palmolive position peaked at $1.35M in Q2 2019.
  • 1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Human Investing's 13F filing for Q4 2024, filed 31 Jan 2025.